Skip to content
Review Open access

Efficacy of Orthokeratology in Controlling Axial Elongation in Myopic Children and Adolescents: A Systematic Review and Meta-Analysis of Comparative Interventions

Jul 2026 · Journal of Clinical Medicine · Vol 15, pp. 5776 · 1 citation · ⚡ 1 influential · 74 references
Medicine

TL;DR

Combination therapies, particularly orthokeratology with atropine, demonstrate additive benefits and high heterogeneity across studies highlights the need for standardized protocols and long-term follow-up studies to optimize myopia control strategies.

Abstract

Background: Myopia represents a growing global public health concern, with prevalence projected to reach 4.9 billion people by 2050. Orthokeratology has emerged as a non-invasive optical intervention for myopia control in children. This systematic review and meta-analysis evaluated the efficacy of orthokeratology in reducing axial length (AL) growth compared to spectacles, atropine combinations, multifocal contact lenses, gradient soft contact lenses, modified orthokeratology with enhanced peripheral defocus (enhanced OK), and atropine therapy with single-vision spectacle correction. Methods: A systematic literature search was conducted in PubMed and Google Scholar for studies published in the past 20 years (2004–2024) using keywords “orthokeratology” OR “corneal reshaping” AND “myopia control.” Inclusion criteria comprised longitudinal clinical studies (randomized or non-randomized) with AL measurements, at least two groups including orthokeratology, and publication in English or Portuguese. Meta-analysis was performed using Review Manager 5.0.25 with random-effects models. Heterogeneity was assessed using I2 statistics, and subgroup analyses were conducted by follow-up duration. Results: Thirty-one studies met inclusion criteria. Orthokeratology significantly reduced AL growth compared to spectacles (25 studies, 4267 patients; mean difference [MD] = −0.16 mm, 95% CI −0.19 to −0.14, p < 0.00001, I2 = 97%). Combined orthokeratology with atropine showed superior efficacy to orthokeratology alone (8 studies, 888 patients; MD = 0.09 mm, 95% CI 0.06 to 0.12, p < 0.00001, I2 = 98%). Orthokeratology demonstrated equivalent efficacy to multifocal contact lenses (3 studies, 208 patients; MD = 0.00 mm, 95% CI −0.04 to 0.05, p = 0.85, I2 = 83%). Atropine therapy with single-vision spectacle correction and enhanced OK showed superior myopia control compared to conventional orthokeratology. Conclusions: Orthokeratology effectively slows axial elongation in myopic children compared to spectacles, with efficacy comparable to multifocal contact lenses. Combination therapies, particularly orthokeratology with atropine, demonstrate additive benefits. High heterogeneity across studies highlights the need for standardized protocols and long-term follow-up studies to optimize myopia control strategies.

Read PDF

Similar papers

Open access Jan 2026

Comparative Evaluation of the Efficacy, Safety, and Corneal Dynamics of Overnight Orthokeratology in Teenagers and Adults With Myopia: A Prospective, Open‐Label Study in Taiwan

Background Myopia is a global public health concern, and its prevalence has been increasing year by year worldwide. Orthokeratology uses gas‐permeable contact lenses to reshape the corneal contour and correct low‐to‐moderate myopia. Orthokeratology has also been shown to reduce myopia progression in children. For adult...

Shiuh-Liang Hsu, Chien-Liang Wu, Maylee Huang et al. · 0 citations
Open access Oct 2026

Efficacy and Safety of Specialty-Designed Orthokeratology Lenses with a Reduced Corneal Central Zone Moulding Area in Children with Low Myopia: A Prospective, Randomised, Controlled Trial.

Orthokeratology effectively slowed axial elongation in children with low myopia and specialty-designed ortho-k lenses with altered corneal reshaping characteristics demonstrated greater inhibition of axial elongation.

Qi Zhang, Chang-Liang Peng, Yi-Shu Wang et al. · 0 citations
Review Open access Sep 2026

The role of compliance in the safe use of orthokeratology lenses in children and adolescents

   Background.  Orthokeratology lenses (OK lenses) are widely used for myopia control in children and adolescents. Their overnight wear has specific effects on ocular surface structures, including the corneal epithelium, tear film, and meibomian glands. Despite advances in OK lens design and materials, the risk of c...

D. Myagkov, S. G. Khomiakov, A. Myagkov et al. · 0 citations
Review Open access Aug 2026

Spectral characteristics of light and their association with myopia progression in children: A systematic review protocol

The rising prevalence of myopia, particularly among children, has emerged as a major global public health concern. Emerging evidence indicates that the spectral composition of light may play a critical role in regulating ocular growth and influencing the onset and progression of myopia. However, the available evidence...

G. K. Agbeshie, I. O. Duah, Albert Kwadjo Amoah Andoh et al. · 0 citations
Review Open access Aug 2026

Combination Treatments for Myopia Progression in Children: A Narrative Review

Despite a growing range of effective monotherapies for childhood myopia control, a subset of children continues to show suboptimal control, prompting interest in combination therapy. This narrative mini-review summarises recent evidence on combining pharmacological, optical, and device-based treatments to slow myopia p...

Loreto V. T. Rose · 0 citations
Open access Sep 2026

Assessing The Impact of Vision Therapy in Pediatric Age Group on The Rate of Myopia Progression: A Randomized Control Trial

Purpose:  To evaluate the effect of a structured vision therapy program in children with myopia by assessing its impact on refractive error progression, axial length, corneal curvature, and binocular visual function. Study Design:  A randomized control trial. Place and Duration of Study:  School of Allied & Health Scie...

Jamshed Ali, Mohammad Nooruz Zamaan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.